Transapical Mechanical Splitting of the AML to Prevent LVOT Obstruction Before TMVR: FIH Experience
We Recommend
Disclosures
Within the last 24 months, I have had financial relationship(s) with the ineligible company or companies listed below:
- Consultant Fee/Honoraria/Speaker's Bureau - Abbott; Medtronic; JenaValve; Edwards Lifesciences; Boston Scientific Corporation; Microport; Neovasc
- Grant Support/Research Contract - Picardia